CDT Equity Inc. SEC filings CDT
CDT Equity Inc. has 368 filings in SEC EDGAR's recent list, going back to Dec 9, 2021. Its latest annual report, Form ARS, was filed on Aug 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 27, 2026 | Oct 27, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2026 | Oct 16, 2026 |
| DEFA14A | Additional proxy material | Aug 12, 2026 | — |
| DEF 14A | Proxy statement | Aug 11, 2026 | Aug 11, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 31, 2026 | Jul 31, 2026 |
| DEF 14A | Proxy statement | Mar 6, 2026 | Mar 6, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 24, 2026 | Feb 24, 2026 |
| DEF 14A | Proxy statement | Jul 8, 2025 | Jul 8, 2025 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2025 | Apr 16, 2025 |
| DEF 14A | Proxy statement | Dec 6, 2024 | Dec 6, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 26, 2024 | Nov 26, 2024 |
| DEFA14A | Additional proxy material | Nov 1, 2024 | — |
| DEFA14A | Additional proxy material | Oct 28, 2024 | — |
| DEF 14A | Proxy statement | Oct 28, 2024 | Oct 28, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2024 | Oct 16, 2024 |
| DEF 14A | Proxy statement | Jan 3, 2023 | Jan 3, 2023 |
| PRE 14A | Preliminary proxy statement | Dec 23, 2022 | Dec 23, 2022 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CDT (Nasdaq), CDTTW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Naples, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1896212
- Former names
- CONDUIT PHARMACEUTICALS INC. (until Aug 7, 2025); Murphy Canyon Acquisition Corp. (until Sep 21, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.